New Hanover Regional Medical Center | |
2131 S 17th St Box 9000, Wilmington, North Carolina 28402 | |
(910) 343-7000 | |
Name | New Hanover Regional Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 2131 S 17th St Box 9000, Wilmington, North Carolina |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 340141 |
NPI Number | 1003985375 |
Organization Name | NEW HANOVER REGIONAL MEDICAL CENTER |
Address | 2131 S 17th St, Wilmington, NC 28401 |
Hospital Type | Rehabilitation Hospital |
Phone Number | 910-343-7000 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
› Verified 7 days ago
NPI Number | 1497346787 |
Organization Name | NOVANT HEALTH NEW HANOVER REGIONAL MEDICAL CENTER LLC |
Address | 1415 Physicians Dr, Wilmington, NC 28401 |
Hospital Type | General Acute Care Hospital |
Phone Number | 910-667-7406 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
› Verified 7 days ago
NPI Number | 1508453754 |
Organization Name | NOVANT HEALTH NEW HANOVER REGIONAL MEDICAL CENTER LLC |
Doing Business As | NOVANT HEALTH NEW HANOVER REHABILITATION HOSPITAL |
Address | 2131 S 17th St, Wilmington, NC 28401 |
Hospital Type | Rehabilitation Hospital |
Phone Number | 910-343-7000 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
› Verified 7 days ago
NPI Number | 1538239397 |
Organization Name | NEW HANOVER REGIONAL MEDICAL CENTER |
Address | 2131 S 17th St, Wilmington, NC 28401 |
Hospital Type | Psychiatric Hospital |
Phone Number | 910-343-7000 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
› Verified 7 days ago
NPI Number | 1548216880 |
Organization Name | NEW HANOVER REGIONAL MEDICAL CENTER |
Address | 2131 S 17th St, Wilmington, NC 28401 |
Hospital Type | General Acute Care Hospital |
Phone Number | 910-343-7000 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
› Verified 7 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
Researchers are developing a health app to incorporate into familiar technology such as a tablet or smartphone that will act as a clinical tool to assess atrial fibrillation, a growing heart ailment.
› Verified 7 days ago
New Hanover Regional Medical Center Acute Care Hospital Location: 2131 S 17th St Box 9000, Wilmington, North Carolina 28402 Phone: (910) 343-7000 | |
Wilmington Treatment Center Acute Care Hospital Location: 2520 Troy Drive, Wilmington, North Carolina 28401 Phone: (910) 762-2727 |